Kidong Kim

3.3k total citations
190 papers, 2.3k citations indexed

About

Kidong Kim is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Kidong Kim has authored 190 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Obstetrics and Gynecology, 82 papers in Reproductive Medicine and 39 papers in Oncology. Recurrent topics in Kidong Kim's work include Endometrial and Cervical Cancer Treatments (76 papers), Ovarian cancer diagnosis and treatment (65 papers) and Cervical Cancer and HPV Research (38 papers). Kidong Kim is often cited by papers focused on Endometrial and Cervical Cancer Treatments (76 papers), Ovarian cancer diagnosis and treatment (65 papers) and Cervical Cancer and HPV Research (38 papers). Kidong Kim collaborates with scholars based in South Korea, United States and Ethiopia. Kidong Kim's co-authors include Jae Hong No, Dong Hoon Suh, Jae‐Weon Kim, Yong Beom Kim, Kicheol Kim, Yong Sang Song, Hyun Hoon Chung, Yong Beom Kim, Banghyun Lee and Hee Seung Kim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kidong Kim

178 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kidong Kim South Korea 26 840 724 500 423 413 190 2.3k
Vincent Lavoué France 24 942 1.1× 670 0.9× 368 0.7× 362 0.9× 705 1.7× 229 2.6k
Ovadia Abulafia United States 31 1.2k 1.5× 756 1.0× 602 1.2× 494 1.2× 725 1.8× 178 3.7k
Lynn P. Parker United States 18 492 0.6× 670 0.9× 260 0.5× 289 0.7× 375 0.9× 36 1.5k
Cláudia Marchetti Italy 33 885 1.1× 1.5k 2.1× 968 1.9× 279 0.7× 649 1.6× 178 3.3k
Innocenza Palaia Italy 36 1.4k 1.7× 1.7k 2.4× 966 1.9× 538 1.3× 885 2.1× 187 3.6k
Violante Di Donato Italy 37 1.6k 1.9× 1.5k 2.1× 813 1.6× 752 1.8× 949 2.3× 214 3.7k
Michael A. Finan United States 24 610 0.7× 387 0.5× 378 0.8× 369 0.9× 533 1.3× 84 1.8k
Ellen M. Hartenbach United States 23 934 1.1× 1.7k 2.3× 800 1.6× 196 0.5× 1.1k 2.7× 76 3.1k
Gunter Deppe United States 27 966 1.1× 941 1.3× 622 1.2× 465 1.1× 845 2.0× 137 2.5k
Hung‐Hsueh Chou Taiwan 37 2.1k 2.5× 1.3k 1.8× 571 1.1× 1.4k 3.3× 1.2k 3.0× 142 3.9k

Countries citing papers authored by Kidong Kim

Since Specialization
Citations

This map shows the geographic impact of Kidong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kidong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kidong Kim more than expected).

Fields of papers citing papers by Kidong Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kidong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kidong Kim. The network helps show where Kidong Kim may publish in the future.

Co-authorship network of co-authors of Kidong Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Kidong Kim. A scholar is included among the top collaborators of Kidong Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kidong Kim. Kidong Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ngoi, Natalie Y.L., Chel Hun Choi, Diana Lim, et al.. (2025). Durvalumab versus Physician’s Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial. Clinical Cancer Research. 31(18). 3907–3915. 2 indexed citations
2.
3.
Kim, Kidong, Hyojin Kim, Yong Beom Kim, et al.. (2023). A simplified two-marker immunohistochemistry strategy for Lynch syndrome screening in endometrial cancer patients. Obstetrics & Gynecology Science. 66(6). 537–544.
4.
Kim, Hyojin, et al.. (2023). Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer. Biomedicines. 11(10). 2691–2691. 5 indexed citations
5.
Ji, Eunjeong, Kidong Kim, Banghyun Lee, et al.. (2022). Postoperative Hormone Replacement Therapy and Survival in Women with Ovarian Cancer. Cancers. 14(13). 3090–3090. 6 indexed citations
6.
Kim, Kidong, Hyojin Kim, Yong Beom Kim, et al.. (2022). Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer. Journal of Gynecologic Oncology. 33(3). e27–e27. 4 indexed citations
7.
8.
Suh, Dong Hoon, et al.. (2021). Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer. International Journal of Molecular Sciences. 22(19). 10255–10255. 6 indexed citations
9.
Suh, Dong Hoon, et al.. (2021). Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy. Diagnostic Pathology. 16(1). 7–7. 11 indexed citations
10.
Kim, Se Ik, Sungyoung Lee, Chel Hun Choi, et al.. (2021). Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer. Cancers. 13(15). 3709–3709. 11 indexed citations
11.
Yuk, Jin‐Sung, et al.. (2021). Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study. PLoS ONE. 16(4). e0250723–e0250723. 5 indexed citations
12.
Jeong, Jin Young, et al.. (2020). Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study. PLoS ONE. 15(12). e0243064–e0243064. 7 indexed citations
13.
Kim, Ju-Hyun, Kidong Kim, Soyeon Ahn, et al.. (2020). Pilot study of radiofrequency thermal therapy performed twice on the entire vaginal wall for vaginal laxity. European Journal of Obstetrics & Gynecology and Reproductive Biology. 254. 159–163. 3 indexed citations
14.
Lee, Jae Young, Kidong Kim, Sung Il Hwang, et al.. (2020). Efficacy and safety of transvaginal high-intensity focused ultrasound therapy in women with symptomatic uterine leiomyomas: A clinical trial. European Journal of Obstetrics & Gynecology and Reproductive Biology. 256. 302–307. 7 indexed citations
15.
16.
Suh, Dong Hoon, Miseon Kim, Kidong Kim, et al.. (2017). Major clinical research advances in gynecologic cancer in 2016: 10-year special edition. Journal of Gynecologic Oncology. 28(3). e45–e45. 24 indexed citations
17.
Ahn, Hyo‐Jeong, Miseon Kim, Dong Hoon Suh, et al.. (2017). Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection. Obstetrics & Gynecology Science. 60(5). 440–440. 7 indexed citations
18.
Suh, Dong Hoon, Jeong‐Yeol Park, Jung‐Yun Lee, et al.. (2015). The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study. Gynecologic Oncology. 137(3). 412–417. 16 indexed citations
19.
Suh, Dong Hoon, Kyung-Hun Lee, Kidong Kim, Sokbom Kang, & Jae‐Weon Kim. (2015). Major clinical research advances in gynecologic cancer in 2014. Journal of Gynecologic Oncology. 26(2). 156–156. 27 indexed citations
20.
Kim, Kidong, et al.. (2014). Efficacy of methotrexate therapy in patients with tubal pregnancy and a serum human chorionic gonadotropin level above 10,000 IU/L. Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine. 41(1). 33–33. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Lavoué Breakdown of academic impact, for papers by Ovadia Abulafia Breakdown of academic impact, for papers by Lynn P. Parker Breakdown of academic impact, for papers by Cláudia Marchetti Breakdown of academic impact, for papers by Innocenza Palaia Breakdown of academic impact, for papers by Violante Di Donato Breakdown of academic impact, for papers by Michael A. Finan Breakdown of academic impact, for papers by Ellen M. Hartenbach Breakdown of academic impact, for papers by Gunter Deppe Breakdown of academic impact, for papers by Hung‐Hsueh Chou
Rankless by CCL
2026